Document Detail

Use of etomidate as an induction agent for rapid sequence intubation in a pediatric emergency department.
MedLine Citation:
PMID:  16636355     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: Although etomidate is widely used for rapid sequence intubation (RSI), there is no consensus on the optimal induction agent and no prospective pediatric emergency department (ED) study exists. The objective of this study was to assess the effectiveness and safety of etomidate as an induction agent for RSI in the pediatric ED. METHODS: Data on RSI conditions and complications were collected prospectively on patients undergoing RSI in a tertiary pediatric ED from January 2003 to December 2003. ED hemodynamic data and inpatient data were collected retrospectively via chart review. RESULTS: Seventy-seven of 101 patients requiring intubation underwent RSI with etomidate. The mean (+/- SD) age was 8.2 (+/- 6.2) years. All 77 patients were successfully intubated. Intubation condition data were available for 69 of 77 patients (89.6%). Conditions were good in 68 of 69 (99%; 95% confidence interval = 92.2% to 99.9%). The mean (+/- SD) maximal percent decrease in systolic blood pressure was 10% (+/- 13.6%). A greater than 20% maximal percent decrease in systolic blood pressure occurred in 12 of 69 patients (17.4%; 95% confidence interval = 9.3% to 28.4%). There was no relationship between seizures after etomidate administration and prior seizure history (p = 0.25). Corticosteroids were given to 29 of 77 patients post-RSI for varying diagnoses. All eight patients given corticosteroids for shock were in shock at the time of intubation. CONCLUSIONS: In the pediatric ED setting, etomidate as an induction agent provided successful RSI conditions and resulted in varied hemodynamic changes that were especially favorable in those patients presenting in decompensated shock. Hypotension and seizures were uncommon and occurred in patients with confounding diagnoses. Until the significance of a single dose of etomidate on adrenal dysfunction is further clarified, caution should be used in those patients at risk for adrenal insufficiency.
Noel S Zuckerbraun; Raymond D Pitetti; Sandra M Herr; Kimberly R Roth; Barbara A Gaines; Christopher King
Related Documents :
17210495 - Sidestream end-tidal carbon dioxide monitoring during helicopter transport.
6496615 - Lacrimal drainage system inflammatory masses from retained silicone tubing.
25384525 - Battery for assessment of neuropsychological status (rbans) in schizophrenia: a pilot s...
9613265 - Requirements for target-controlled infusion of propofol to insert the laryngeal mask ai...
23761015 - Novel oral anticoagulants for atrial fibrillation.
2448995 - Leukocyte migration in vivo and in vitro in patients with psoriasis.
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2006-04-24
Journal Detail:
Title:  Academic emergency medicine : official journal of the Society for Academic Emergency Medicine     Volume:  13     ISSN:  1553-2712     ISO Abbreviation:  Acad Emerg Med     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-06-01     Completed Date:  2006-07-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9418450     Medline TA:  Acad Emerg Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  602-9     Citation Subset:  IM    
Division of Pediatric Emergency Medicine, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Cortex Hormones / therapeutic use
Blood Pressure / drug effects
Child, Preschool
Emergency Medicine / methods*
Emergency Service, Hospital*
Etomidate / therapeutic use*
Heart Rate / drug effects
Hypnotics and Sedatives / therapeutic use*
Hypotension / chemically induced
Infant, Newborn
Intubation, Intratracheal / adverse effects,  methods*
Pediatrics / methods*
Prospective Studies
Seizures / chemically induced
Shock / etiology,  therapy
Survival Analysis
Treatment Outcome
Wounds and Injuries / complications,  therapy
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Hypnotics and Sedatives; 33125-97-2/Etomidate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Tibiofemoral contact mechanics after serial medial meniscectomies in the human cadaveric knee.
Next Document:  Portable advanced medical simulation for new emergency department testing and orientation.